Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on September 14, 2007.
Experimental Physiology (2007)
DOI: 10.1113/expphysiol.2007.038612
© The Physiological Society 2007

A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/1/148    most recent
expphysiol.2007.038612v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wray, J. A
Right arrow Articles by Bishop-Bailey, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wray, J. A
Right arrow Articles by Bishop-Bailey, D.

Received June 25, 2007
Revised August 20, 2007
Accepted after revision September 5, 2007


Cardiovascular Control [210]

Epoxygenases and PPARs in vascular biology

Jessica A Wray 1 David Bishop-Bailey 1*

1 Queen Mary University London

* To whom correspondence should be addressed. E-mail: d.bishop-bailey{at}qmul.ac.uk.


   Abstract
Epoxygenases, particularly of the CYP2C and CYP2J families represent important lipid metabolising enzymes. Epoxygenases are found throughout the cardiovascular system where their lipid products, particularly the arachidonic acid metabolites, the epoxyeicosatrienoic acids (EETs) have the potential to regulate vascular tone, cell proliferation, migration, inflammation and cardiac function. The receptors for EETs are however poorly understood. The peroxisome proliferator-activated receptors (PPAR)s are a family of 3 ({alpha}, {beta}/{delta}, {gamma}) nuclear receptors that are activated by lipid metabolites. Activation of PPAR{alpha} and PPAR{gamma}, similar to the longer term effects of EETs, causes the inhibition of vascular cell proliferation, migration and inflammation. Interestingly, EETs and their metabolites have recently been found to active both PPAR{alpha} and PPAR{gamma}. The epoxygenase-EET-PPAR pathway may therefore represent a novel endogenous protective pathway by which short lived lipid mediators control vascular cell activation.

Key Words: Endothelial cell, Inflammation, Smooth muscle







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the The Physiological Society.